VETERINARY REGENERATIVE TECHNOLOGY
REGENERATION
STARTS
WITH THE
PATIENT.
OWN CELLS. NATURAL HEALING.
In-Clinic Preparation • Single Session • Autologous Approach • Biocompatible
%100
Otolog
Single
Session
Enzyme-Free
PROCESS
In-Clinic
Application
FROM THE PATIENT’S OWN TISSUE.
IN-CLINIC REGENERATION
100% Autologous
•
20-Minute Preparation
•
Single-Session Workflow
100% AUTOLOGOUS
Biological material is obtained from the patient’s own tissue,
supporting high biocompatibility and
helping reduce the risk of immune reactions.
SINGLE SESSION
The autologous cellular preparation can be prepared and applied
during the same clinical session,
supporting a streamlined single-session workflow.
20 MINUTES
SVF preparation is completed in approximately 20 minutes
and is ready for use within the same clinical workflow.
CLOSED SYSTEM
ENZYME-FREE PROCESS
The closed-system design helps reduce contamination risk.
The enzyme-free preparation approach
supports a standardized and practical in-clinic workflow.
HIGH CELL
VIABILITY
Photoactivation technology is integrated into the workflow
to support cellular activity and viability.
FROM TISSUE COLLECTION TO APPLICATION
A FOUR-STEP WORKFLOW.
TISSUE COLLECTION
Tissue Collection
An adipose tissue sample is collected from an appropriate anatomical site.
SEPARATION
Separation
The tissue undergoes controlled mechanical disaggregation and filtration.
PREPARATION
Preparation
The autologous cellular material is prepared on the GCell-Vet platform within the same session.
APPLICATION
Application
The prepared autologous material is ready for clinical application within the same session.
100% AUTOLOGOUS
SVF
IS NOT A SINGLE CELL.
IT IS A HETEROGENEOUS CELL POPULATION.
Stromal Vascular Fraction (SVF) is a natural, heterogeneous
cellular fraction derived from adipose tissue.
Vascular stability and regenerative support
Angiogenesis and tissue perfusion
Immune modulation
Regulation of the immune response
Vascular structure and tissue integrity
Regenerative cellular components
ONE PLATFORM
THE COMPLETE CLINICAL WORKFLOW.
An integrated clinical system combining the main device,
sterile single-use kits, and a photoactivation-supported workflow.
Closed-system approach
Regenerative technology
Designed for clinical workflow
01
Core Platform
The GCell-Vet technology platform
developed for photoactivation-supported preparation.
02
Sterile Single-Use Kits
A sterile, single-use clinical consumable system
designed to standardize the SVF preparation workflow.
03
SVF & PRP
A flexible platform supporting
photoactivation in PRP applications alongside SVF protocols.
04
In-Clinic Use
An integrated system supporting preparation and application
within the same clinical workflow.
ONE PLATFORM
DIFFERENT CLINICAL NEEDS.
GCell-Vet is an autologous biological material preparation
platform adaptable to a range of regenerative applications in veterinary medicine.
Orthopaedics & Joints
An in-clinic approach to preparing autologous regenerative material
for joint and orthopaedic applications.
Tendon & Ligament
An autologous regenerative approach
for tendon, ligament and soft-tissue applications.
Chronic Wounds & Tissue
A clinical approach designed to support regenerative processes
in chronic and hard-to-heal wounds.
Dermatology & Alopecia
Regenerative veterinary applications designed to
support dermatologic health and skin integrity.
Oral & Dental
Veterinary regenerative applications aimed at
supporting oral and periodontal tissues.
Equine Applications
A platform adaptable to tendon, orthopaedic and performance-focused
regenerative applications in equine medicine.
100% AUTOLOGOUS APPROACH
EQUINE
REGENERATION WITH AN
AUTOLOGOUS APPROACH.
A next-generation in-clinic regenerative approach based on
the patient’s own biological material
for cartilage, joint, tendon and soft-tissue applications.
Cartilage Disorders
Regenerative applications for cartilage and joint tissues.
Joint Disorders
Clinical applications aimed at supporting joint function.
Tendon & Ligament Injuries
A regenerative approach for tendon and ligament tissues.
Skin Diseases
Regenerative support for skin and soft-tissue applications.
SCIENTIFIC EVIDENCE.
THE BASIS OF CLINICAL DECISION
Selected publications and clinical examples from the regenerative veterinary medicine,
micrograft and autologous cellular material literature
underlying the GCell-Vet approach.
01
Osteoarthritis and
Microfragmented Adipose Tissue
A scientific study evaluating joint function
and regenerative approaches in dogs.
02
Chronic Wounds and
Tissue Regeneration
published clinical case involving
dermal micrograft application.
03
Cartilage and
Mechanical Micrografts
Literature evaluating mechanical micrograft
technology in equine cartilage applications.
THE BEST BIOLOGICAL MATERIAL
COMES FROM THE PATIENT.
The starting point of a regenerative approach is
the patient’s own biological potential.
AUTOLOGOUS
BIOLOGICAL
INDIVIDUAL
FROM SVF TO PRP.
ONE PLATFORM WITH INTEGRATED PHOTOACTIVATION.
01
Photoactivation
Photoactivation technology operating within the 600–900 nm wavelength range
is integrated into the workflow to support
cellular activity and viability within the SVF cell population.
02
SVF Protocol
The autologous cellular fraction derived from adipose tissue
is prepared in-clinic and can be administered back
to the patient within the same session.
03
PRP Applications
GCell-Vet is not limited to SVF. In PRP protocols, photoactivation
can be applied directly using a syringe without a dedicated kit,
with the aim of supporting cellular viability and biological activity.
04
High Cell Viability
The preparation and photoactivation workflow is designed
to help preserve high viability in the resulting cellular material.
GET IN
TOUCH.
Vetinnovate
LOCATION · İstanbul, Türkiye
FOR CLINICS &
DISTRIBUTORS.
Choose the right contact channel for veterinary clinics in Turkey
and prospective international distributors.
TURKEY • VETERINARIANS & CLINICS
BRING GCELL-VET INTO YOUR
CLINIC PRACTICE.
Contact the GCell-Vet team directly for product information,
clinical applications, demos and training.
01
INTERNATIONAL PARTNERSHIPS
Become a GCell-Vet
Distributor.
Interested in representing GCell-Vet in your market?
Contact us to discuss international distribution and
partnership opportunities.
02